Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.
about
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)Association between cell-bound blood amyloid-β(1-40) levels and hippocampus volumeIdentification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study.Factors affecting Aβ plasma levels and their utility as biomarkers in ADNINutrient intake and plasma β-amyloid.The demographic and medical correlates of plasma aβ40 and aβ42Neurochemical biomarkers in Alzheimer's disease and related disorders.Age-dependent inverse correlations in CSF and plasma amyloid-β(1-42) concentrations prior to amyloid plaque deposition in the brain of 3xTg-AD miceEffects of Heart Bypass Surgery on Plasma Aβ40 and Aβ42 Levels in Infants and Young Children.Non-invasive screening for early Alzheimer's disease diagnosis by a sensitively immunomagnetic biosensor.Increased levels of antigen-bound β-amyloid autoantibodies in serum and cerebrospinal fluid of Alzheimer's disease patients.Improved protocol for measurement of plasma β-amyloid in longitudinal evaluation of Alzheimer's Disease Neuroimaging Initiative study patientsPlasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis.Validation of Immunoassay-Based Tools for the Comprehensive Quantification of Aβ40 and Aβ42 Peptides in Plasma.Active duty service members who sustain a traumatic brain injury have chronically elevated peripheral concentrations of Aβ40 and lower ratios of Aβ42/40.Plasma amyloid-β levels and prognosis in incident dementia cases of the 3-City StudyMeta-analysis of plasma amyloid-β levels in Alzheimer's disease.Neurodegeneration, β-amyloid and mood disorders: state of the art and future perspectives.Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.Risk factors for the progression of mild cognitive impairment to dementia.Biomarker modelling of early molecular changes in Alzheimer's disease.Elevated Plasma Aβ42 in Cognitively Impaired Individuals Taking ACE Inhibitor Antihypertensives.A Systematic Review of Longitudinal Studies Which Measure Alzheimer's Disease Biomarkers.Alterations in the Levels of Amyloid-β, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer's Disease: Possible Interactions between Amyloid-β and These Lipids.Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer's disease and vascular dementia.Effects of folic acid supplementation on cognitive function and Aβ-related biomarkers in mild cognitive impairment: a randomized controlled trail.Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease.Association of Plasma β-Amyloid with Cognitive Performance and Decline in Chronic Kidney Disease.Stability of amyloid-β peptides in plasma and serum.Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer's disease.
P2860
Q24193707-96B22631-0EA0-438C-892B-442600A9FE62Q34630564-8EA1691B-8E2D-44D3-A648-6F2E56F2A1C1Q35085348-1C287FBC-0049-4329-8DE3-8B91AFB64FC3Q35821382-00C1D616-5C7F-430E-8F9F-04AFF672636EQ36014708-86DED98B-1FF3-41E5-94DC-FD7DA79FC06CQ36322974-0AAF618D-A71C-4251-AEBE-2C456FC897D0Q36366891-8500189D-4E80-4A9A-9ED6-5FEB42B4FB91Q36528218-F9DBC96A-207A-4300-B219-9F24FCDB235BQ36580926-4BFDF9F3-0866-4423-AEDF-EFD7917E22F2Q36835545-8AF19D49-3B10-4BD5-92B6-C15557FBC9CCQ37024947-9EEA4BE4-89AC-47D8-ADF8-34E140791A65Q37066036-2D2E3447-CC41-4FF4-AAA5-08977545EC2AQ37169576-569830C2-772D-42D8-AD69-DFB88FDA7644Q37300264-B4F2846A-7FC3-4EDF-8D57-F3D00E13793DQ37494841-88AA48C4-7ABF-421B-AE39-DA034FDAA2FBQ37693190-AF17C521-C923-4196-9B33-2020F7474FC7Q37895050-4515C25D-0907-48BB-8749-8300805CD9E1Q38045223-BD9BF79F-42C1-4F13-93B2-B97F4A49050CQ38125769-4ADB72B7-9A40-4BEB-8C4E-5701ECD368D8Q38149355-73AAFBDF-8B69-455D-B107-6C7C41131E6BQ38166669-716314FA-255D-4676-BBD8-75ED8875D9BFQ38690145-46C7C541-3B9A-4853-84F2-ACA92E2259AFQ40101067-30984A7F-D7C0-4D50-A408-29293B0A5F0FQ40196236-FF423112-8BD4-4FCA-804C-FD94B9D377A3Q44884500-63919DA2-2D9C-49BF-A7B1-F0744337C996Q47285255-5CE9CB4F-43FA-4220-8E91-7B6DEA7DF225Q48409075-A576214A-1B4E-4929-9E41-DDD38E86D00DQ48450061-BE6E0E19-A677-451B-8F3F-3CBA73EF844FQ50771095-30DBDD6A-66BE-46F4-ADAA-2B7A1DCC95EEQ50902089-E72AD2F9-CE77-41F3-8C18-823247534D55Q53328612-4EF30740-5CC5-45EC-B893-074AC72FD4BB
P2860
Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Plasma Abeta42 and Abeta40 as ...... population-based cohort study.
@ast
Plasma Abeta42 and Abeta40 as ...... population-based cohort study.
@en
Plasma Abeta42 and Abeta40 as ...... population-based cohort study.
@nl
type
label
Plasma Abeta42 and Abeta40 as ...... population-based cohort study.
@ast
Plasma Abeta42 and Abeta40 as ...... population-based cohort study.
@en
Plasma Abeta42 and Abeta40 as ...... population-based cohort study.
@nl
prefLabel
Plasma Abeta42 and Abeta40 as ...... population-based cohort study.
@ast
Plasma Abeta42 and Abeta40 as ...... population-based cohort study.
@en
Plasma Abeta42 and Abeta40 as ...... population-based cohort study.
@nl
P2093
P2860
P356
P1476
Plasma Abeta42 and Abeta40 as ...... population-based cohort study.
@en
P2093
M Hallikainen
S-K Herukka
T Hänninen
T Pirttilä
T T Seppälä
P2860
P304
P356
10.1136/JNNP.2010.205757
P407
P577
2010-05-16T00:00:00Z